Exercise of SAYE Options and PDMR Dealing
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
CVS, one of the UK's leading providers of integrated veterinary services, announces that on 10 January 2024, options over a total of 41,174 ordinary shares of 0.2 pence each (the "Ordinary Shares") were exercised under the CVS Group 2020 SAYE Plan (2020/2024), at an exercise price of £10.09.
The issuance of shares in connection with the SAYE Exercise was fully satisfied by 41,174 Ordinary Shares held by the CVS Group Employee Benefit Trust (the "EBT"). Following the SAYE Exercise, a total of 6,771 Ordinary Shares are held by the EBT, representing approximately 0.009% of the Company's total voting rights.
Richard Fairman, Chief Executive Officer exercised options over 606 Ordinary Shares in the Company. The balance of the options were exercised by certain other employees and former employees of the Company.
Following his option exercise, Richard Fairman, along with any persons closely associated, holds a beneficial interest in 78,107 Ordinary Shares in the Company, representing approximately 0.109% of the total voting rights of the Company, calculated on the same basis.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Richard Fairman | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | Chief Executive Officer | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 0.2 pence each GB00B2863827 | ||||
| b) | Nature of the transaction | Exercise of options under the 2020 SAYE Plan (1 January 2024 maturity) | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 10 January 2024 | ||||
| f) | Place of the transaction | London Stock Exchange - AIM |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.